Page last updated: 2024-08-23

daunorubicin and interleukin-8

daunorubicin has been researched along with interleukin-8 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
de Bont, ES; Kamps, WA; Koetse, HA; Rings, EH; Stellaard, F; Tissing, WJ; van Vliet, MJ1
Fang, Z; Feng, Y; Khadka, B; Liu, J; Wu, J; Zhang, L1

Trials

1 trial(s) available for daunorubicin and interleukin-8

ArticleYear
Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Acute Disease; Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carbohydrates; Cell Death; Child; Child, Preschool; Citrulline; Cytarabine; Daunorubicin; DNA; Enterocytes; Etoposide; Feces; Female; Humans; Infant; Interleukin-8; Intestinal Absorption; Leukemia, Myeloid; Leukocyte L1 Antigen Complex; Male; Mitoxantrone; Models, Biological; Mucositis; Stomatitis

2009

Other Studies

1 other study(ies) available for daunorubicin and interleukin-8

ArticleYear
HDAC8 promotes daunorubicin resistance of human acute myeloid leukemia cells via regulation of IL-6 and IL-8.
    Biological chemistry, 2021, 03-26, Volume: 402, Issue:4

    Topics: Antibiotics, Antineoplastic; Cell Proliferation; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Histone Deacetylases; Humans; Interleukin-6; Interleukin-8; Leukemia, Myeloid, Acute; Repressor Proteins; RNA, Small Interfering; Tumor Cells, Cultured

2021